$146.47
-0.92-0.62%
At close: -
$145.70
-0.77-0.53%
After Hours: 7:14 PM EDT
Comments
Loading...
Latest news for Biogen (NASDAQ:BIIB) Stock
Biogen Stock (NASDAQ: BIIB)
Categories: All
Friday, December 20, 2024
Wednesday, December 11, 2024
Tuesday, December 10, 2024
Monday, December 09, 2024
Thursday, December 05, 2024
Wednesday, December 04, 2024
Tuesday, December 03, 2024
Monday, December 02, 2024
Friday, November 29, 2024
Tuesday, November 26, 2024
Thursday, November 21, 2024
Wednesday, November 20, 2024
Tuesday, November 19, 2024
Monday, November 18, 2024
Friday, November 15, 2024
Thursday, November 14, 2024
Monday, November 04, 2024
Friday, November 01, 2024
Thursday, October 31, 2024
- Oppenheimer Maintains Outperform on Biogen, L...
- Barclays Maintains Equal-Weight on Biogen, Lo...
- Biogen Analysts Slash Their Forecasts After Q3 Results
- TD Cowen Maintains Buy on Biogen, Lowers Pric...
- This Kraft Heinz Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
- HC Wainwright & Co. Reiterates Buy on Biogen,...
- Needham Reiterates Buy on Biogen, Maintains $...
- Morgan Stanley Downgrades Biogen to Equal-Wei...
- Reported Earlier, Eisai And Biogen Reveal Fiv...
Wednesday, October 30, 2024
- Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
- Biogen's Q3 Profit Beats Expectations On Lower Multiple Sclerosis Revenues But New Products Offset Losses, Raises Profit Outlook
- Biogen Raised Its 2024 Adjusted EPS Guidance ...
- Needham Reiterates Buy on Biogen, Maintains $...
- Biogen Q3 2024 Adj EPS $4.08 Beats $3.79 Esti...